112 related articles for article (PubMed ID: 11282244)
1. Activity of mammalian secreted phospholipase A(2) from inflammatory peritoneal fluid towards PEG-liposomes. Early indications.
Vermehren C; Jørgensen K; Schiffelers R; Frokjaer S
Int J Pharm; 2001 Feb; 214(1-2):93-8. PubMed ID: 11282244
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a lipid-membrane destabilizing enzyme with PEG-liposomes.
Jørgensen K; Kiebler T; Hylander I; Vermehren C
Int J Pharm; 1999 Jun; 183(1):21-4. PubMed ID: 10361147
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery by phospholipase A(2) degradable liposomes.
Davidsen J; Vermehren C; Frokjaer S; Mouritsen OG; Jørgensen K
Int J Pharm; 2001 Feb; 214(1-2):67-9. PubMed ID: 11282239
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A(2)-susceptible liposomes of anticancer double lipid-prodrugs.
Arouri A; Mouritsen OG
Eur J Pharm Sci; 2012 Mar; 45(4):408-20. PubMed ID: 21946258
[TBL] [Abstract][Full Text] [Related]
5. Increase in phospholipase A2 activity towards lipopolymer-containing liposomes.
Vermehren C; Kiebler T; Hylander I; Callisen TH; Jørgensen K
Biochim Biophys Acta; 1998 Aug; 1373(1):27-36. PubMed ID: 9733909
[TBL] [Abstract][Full Text] [Related]
6. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
[TBL] [Abstract][Full Text] [Related]
7. Influence of lipopolymer concentration on liposome degradation and blood clearance.
Vermehren C; Jørgensen K; Frokjaer S
Int J Pharm; 1999 Jun; 183(1):13-6. PubMed ID: 10361145
[TBL] [Abstract][Full Text] [Related]
8. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
[TBL] [Abstract][Full Text] [Related]
9. Poly(ethylene glycol)-lipid conjugates inhibit phospholipase C-induced lipid hydrolysis, liposome aggregation and fusion through independent mechanisms.
Basáñez G; Goñi FM; Alonso A
FEBS Lett; 1997 Jul; 411(2-3):281-6. PubMed ID: 9271221
[TBL] [Abstract][Full Text] [Related]
10. Cascade liposomal triggering: light-induced Ca2+ release from diplasmenylcholine liposomes triggers PLA2-catalyzed hydrolysis and contents leakage from DPPC liposomes.
Wymer NJ; Gerasimov OV; Thompson DH
Bioconjug Chem; 1998; 9(3):305-8. PubMed ID: 9576803
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of phospholipase A2 catalyzed degradation of polymer grafted PEG-liposomes: effects of lipopolymer-concentration and chain-length.
Jørgensen K; Vermehren C; Mouritsen OG
Pharm Res; 1999 Sep; 16(9):1491-3. PubMed ID: 10496671
[No Abstract] [Full Text] [Related]
12. Lipid peroxidation and phospholipase A2 activity in liposomes composed of unsaturated phospholipids: a structural basis for enzyme activation.
Sevanian A; Wratten ML; McLeod LL; Kim E
Biochim Biophys Acta; 1988 Aug; 961(3):316-27. PubMed ID: 3401498
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
14. Screening effect of PEG on avidin binding to liposome surface receptors.
Kaasgaard T; Mouritsen OG; Jørgensen K
Int J Pharm; 2001 Feb; 214(1-2):63-5. PubMed ID: 11282238
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes.
Moribe K; Maruyama K; Iwatsuru M
Int J Pharm; 2000 May; 201(1):37-49. PubMed ID: 10867263
[TBL] [Abstract][Full Text] [Related]
16. Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomes.
Hossann M; Syunyaeva Z; Schmidt R; Zengerle A; Eibl H; Issels RD; Lindner LH
J Control Release; 2012 Sep; 162(2):400-6. PubMed ID: 22759980
[TBL] [Abstract][Full Text] [Related]
17. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
[TBL] [Abstract][Full Text] [Related]
18. Peroxidation and phospholipase A2 hydrolytic susceptibility of liposomes consisting of mixed species of phosphatidylcholine and phosphatidylethanolamine.
Salgo MG; Corongiu FP; Sevanian A
Biochim Biophys Acta; 1992 Jul; 1127(2):131-40. PubMed ID: 1643097
[TBL] [Abstract][Full Text] [Related]
19. Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether.
Ishiwata H; Vertut-Doï A; Hirose T; Miyajima K
Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1005-11. PubMed ID: 7641302
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of secretory phospholipase A(2) enzyme by bilirubin: a new role as endogenous anti-inflammatory molecule.
Jameel NM; Frey BM; Frey FJ; Gowda TV; Vishwanath BS
Mol Cell Biochem; 2005 Aug; 276(1-2):219-25. PubMed ID: 16132704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
